This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Jozo Delic: Innovator in Nanotechnology for Therapeutic Applications
Introduction
Jozo Delic is a notable inventor based in Bourg la Reine, France. He has made significant contributions to the field of nanotechnology, particularly in the therapeutic applications of nanodiamonds. His innovative approach focuses on utilizing nanodiamonds to generate free radicals for treating tumors, showcasing the potential of nanotechnology in medicine.
Latest Patents
Jozo Delic holds a patent titled "Use of nanodiamonds for generating free radicals for therapeutic purposes under radiation." This invention relates to the use of nanodiamonds as drugs that generate free radicals, especially for tumor treatment. The invention is based on the principle that free radicals can be generated on the surface of nanodiamonds when exposed to radiation, such as ionizing radiation. To enhance the effectiveness of the nanodiamonds, they can be complexed with radiosensitizing agents, including chemical molecules or interfering RNA targeting repairing genes. He has 1 patent in this innovative area.
Career Highlights
Throughout his career, Jozo Delic has worked with prominent organizations, including the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Acubens. His work in these institutions has allowed him to explore and develop groundbreaking technologies in the field of nanomedicine.
Collaborations
Jozo has collaborated with esteemed colleagues such as Romain Grall and Sylvie Chevillard. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Jozo Delic's work in the application of nanodiamonds for therapeutic purposes represents a significant advancement in medical technology. His innovative approach has the potential to transform cancer treatment and improve patient outcomes.